© 2021 MJH Life Sciences and Pharmacy Times. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmacy Times. All rights reserved.
July 06, 2021
The study authors said that these findings could be used to help identify healthy people who are at risk for the condition before they have symptoms.
June 28, 2021
Hypertension is a risk factor for cognitive decline and dementia in older adults.
June 25, 2021
Myokine cathepsin B, brain-derived neurotrophic factor, and klotho were all found to be influential in delaying the progression of Alzheimer disease.
June 21, 2021
Study indicates that some instrumental music is more likely to cause earworms and disrupt sleep quality compared with lyrical music.
June 17, 2021
The FDA recently approved the amyloid beta-directed antibody indicated for the treatment of the progressive disease.
The study authors examined data from the Health and Retirement Study, which included 2496 individuals who were at least 51 years of age.
June 10, 2021
Pharmacy Times spoke to Dr. Douglas Scharre, neurologist and director of the division of Cognitive Neurology at Ohio State Wexner Medical Center, about the latest FDA approved drug for Alzheimer disease.
June 09, 2021
The study authors sought to evaluate whether the link between lifestyle and cognition varies by APOE genotype among the elderly.
June 01, 2021
The tool measures brain health based on cognitive performance and may be used in the future to predict the likelihood that an individual will develop memory and thinking problems as they age.
May 24, 2021
According to the study authors, this model provides insights into the multiscale biological alterations in the elderly and neurodegenerative brain, which have important implications for identifying treatment targets for Alzheimer disease.